Bremer Bank National Association Biogen Inc. Transaction History

Bremer Bank National Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$258.66 - $342.55 $980,062 - $1.3 Million	-3,789 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$268.85 - $341.04 $6,721 - $8,526	25 Added 0.66%	3,789 $1.2 Million
Q4 2019 Jan 27, 2020	BUY	$220.06 - $304.07 $3,080 - $4,256	14 Added 0.37%	3,764 $1.12 Million
Q3 2019 Oct 03, 2019	SELL	$217.44 - $243.88 $92,629 - $103,892	-426 Reduced 10.2%	3,750 $873,000
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $9,648 - $10,635	44 Added 1.06%	4,176 $977,000
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $895,445 - $1.4 Million	4,132 New	4,132 $947,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

Stay updated on Bremer Bank National Association with notifications on news.